Meprobamate
- Product NDC
- 52549-4147
- 11-digit product format
- 525494147
- Labeler code
- 52549
- Product ID
- 52549-4147_a1a2d874-5b9c-4f21-bb21-8757f2468b2a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meprobamate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Taro Pharmaceutical Industries Ltd.
- Application
- ANDA200998
- Marketing category
- ANDA
- Marketing start
- 2011-05-23
- Marketing end
- 0000-00-00
- Substance
- MEPROBAMATE
- Active strength
- 200 mg/1
- DEA schedule
- CIV
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b9268013-e5ec-7d19-0af8-fce7c9afbdb1 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52549-4147-1 | 2025-11-05 | C162847 | 48780-1 | 9d75b9d0-1ec4-f424-e053-dadaa90a57ce | Meprobamate Tablets USP |
| 52549-4147-3 | 2025-11-05 | C162847 | 48780-1 | 9d75b9d0-1ec4-f424-e053-dadaa90a57ce | Meprobamate Tablets USP |
| 52549-4147-6 | 2025-11-05 | C162847 | 48780-1 | 9d75b9d0-1ec4-f424-e053-dadaa90a57ce | Meprobamate Tablets USP |
| 52549-4147-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1ec4-f424-e053-dadaa90a57ce | Meprobamate Tablets USP |
| 52549-4147-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1ec4-f424-e053-dadaa90a57ce | Meprobamate Tablets USP |
| 52549-4147-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1ec4-f424-e053-dadaa90a57ce | Meprobamate Tablets USP |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Meprobamate | ACTIVE INGREDIENT | 9I7LNY769Q | MEPROBAMATE TABLET [TARO PHARMACEUTICAL INDUSTRIES LTD.] | 1 | |
| Meprobamate | ACTIVE MOIETY | 9I7LNY769Q | MEPROBAMATE TABLET [TARO PHARMACEUTICAL INDUSTRIES LTD.] | 1 | |
| cellulose, microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | MEPROBAMATE TABLET [TARO PHARMACEUTICAL INDUSTRIES LTD.] | 1 | |
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | MEPROBAMATE TABLET [TARO PHARMACEUTICAL INDUSTRIES LTD.] | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | MEPROBAMATE TABLET [TARO PHARMACEUTICAL INDUSTRIES LTD.] | 1 | |
| stearic acid | INACTIVE INGREDIENT | 4ELV7Z65AP | MEPROBAMATE TABLET [TARO PHARMACEUTICAL INDUSTRIES LTD.] | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 52549-4147 | MEPROBAMATE TABLET [TARO PHARMACEUTICAL INDUSTRIES LTD.] | 1 | Legacy NDC | 20110816_e9aa3d4c-f2e9-4ca9-b563-85fac4024539.zip |